• Even when the cause of metabolic coma seems clear, consider an arterial ammonia level.
held with normalization of the level by postoperative day 4. On postoperative day 5, she had persistent arrhythmic twitching of her left arm that within a minute generalized to a full-blown convulsive status epilepticus. Multiple doses of Ativan, totaling 10 mg, and 20 mg/kg PE of fosphenytoin were administered, with cessation of seizures. An ammonia level was obtained and was unreadable at greater than 1,200 g/dL. AST was 36 U/L. Lactulose, rifaximin, and continuous venous-venous hemofiltration (CVVH) were initiated to normalize the ammonia level and continuous EEG monitoring was initiated. An intraparenchymal intracranial pressure (ICP) monitor was placed but the initial intracranial pressure was 4 mm Hg. Two hours after initial cessation of seizures, she had recurrent left arm twitching, which quickly generalized and was refractory to additional 4 mg/kg PE of fosphenytoin, maximal infusion rates of midazolam and propofol, and ultimately was controlled with pentobarbital infusion at a rate of 5 mg/kg/h, at which point the background changed from a pattern of generalized spike and waves to a completely suppressed background in the 1-to 2-Hz range without reactivity. Clinical seizures became under control within 1 hour after onset. Full resolution of electrographic status epilepticus took 6 hours longer. At that time, propofol and midazolam were stopped. Lactulose, rifaximin, and CVVH were continued and arterial ammonia declined gradually. After arterial ammonia had normalized, pentobarbital was slowly weaned. Her ICP remained below 10 mm Hg with the exception of 2 isolated spikes to 19 mm Hg lasting several minutes each on postoperative days 8 and 9. A repeat CT scan of the head on postoperative day 11 showed lack of gray-white matter differentiation and absence of sulci (figure). When the pentobarbital was no longer detectable in her blood, the patient was declared brain dead. edly elevated plasma ammonia levels in the absence of obvious liver disease or any other identifiable cause, and frequently results in persistent coma. Seizures are common among this subset of patients and can be refractory, as was the case with our patient.
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Evidence of elevated intracranial pressure by invasive monitoring or neuroimaging findings of diffuse cerebral edema is reportedly common but was observed late in our patient. [1] [2] [3] [4] [5] [6] When it did occur in our patient it was in the form of surges lasting minutes, making it unlikely that ICP management other than the aggressive treatment of the hyperammonemia would have had any additional benefit.
Increased ammonia is a completely unexpected metabolic derangement in patients with organ transplantation other than liver transplantation. There was no evidence of intraoperative hypotension in our patient to explain the hyperammonemia. Seizures have traditionally been linked to IV loading with calcineurin inhibitors, explaining why neurotoxicity, despite trough levels within the anticipated range, was initially considered in our patient. The prevalence of this major complication leading to massive cerebral edema with refractory status epilepticus remains unclear and failure to measure arterial ammonia may lead to underdetection. Although the etiology of this syndrome is not yet fully elucidated, it appears to be multifactorial in nature. Potential contributing factors include pharmacologic agents, underlying enzymatic deficiencies, infection, or highly catabolic conditions. The rare occurrence of IHE in this population may suggest a preexisting defect in the urea cycle stressed by a major transplant procedure. While there are certainly specific anesthetic considerations in patients with a known enzymatic deficiency, 7 hyperammonemia has not been reported to occur in enzymatically normal patients with the anesthetic agents our patient received. The cerebral edema may reflect the osmotic effect of accumulated intracellular glutamine, the primary metabolic product of ammonia metabolism in the brain. 8 Optimal management remains to be formally established. While some patients do recover full neurologic function, the syndrome is frequently fatal. Whether early recognition and treatment of hyperammonemia (with prompt administration of lactulose and nonabsorbable antibiotics, aggressive management of cerebral edema with osmotic agents, hypothermia, and perhaps dialysis devices to accelerate the reduction in serum ammonia concentration) can change the devastating course of the most severe cases remains to be determined.
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